Citation: Cp. Rains et al., CEFTAZIDIME - AN UPDATE OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY, Drugs, 49(4), 1995, pp. 577-617
Citation: A. Markham et Hm. Bryson, EPOETIN ALFA - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN NONRENAL APPLICATIONS, Drugs, 49(2), 1995, pp. 232-254
Citation: Cp. Rains et al., CABERGOLINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN THE TREATMENT OF HYPERPROLACTINEMIA AND INHIBITION OFLACTATION, Drugs, 49(2), 1995, pp. 255-279
Citation: Lr. Wiseman et Hm. Bryson, PORCINE-DERIVED LUNG SURFACTANT - A REVIEW OF THE THERAPEUTIC EFFICACY AND CLINICAL TOLERABILITY OF A NATURAL SURFACTANT PREPARATION (CUROSURF(R)) IN NEONATAL RESPIRATORY-DISTRESS SYNDROME (VOL 48, PG 386, 1994), Drugs, 49(1), 1995, pp. 70-70
Citation: Ja. Balfour et Hm. Bryson, VALPROIC ACID - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN INDICATIONS OTHER THAN EPILEPSY, CNS DRUGS, 2(2), 1994, pp. 144-173
Citation: Kl. Dechant et Hm. Bryson, THYMOSTIMULIN - A REVIEW OF ITS PHARMACOLOGY AND PROSPECTIVE ROLE IN IMMUNOTHERAPY, CLINICAL IMMUNOTHERAPEUTICS, 1(5), 1994, pp. 378-398
Citation: Hm. Bryson et R. Whittington, COLFOSCERIL PALMITATE - A PHARMACOECONOMIC EVALUATION OF A SYNTHETIC SURFACTANT PREPARATION (EXOSURF(R) NEONATAL(TM)) IN INFANTS WITH RESPIRATORY-DISTRESS SYNDROME, PharmacoEconomics, 6(6), 1994, pp. 563-577
Citation: R. Davis et Hm. Bryson, CEFTRIAXONE - A PHARMACOECONOMIC EVALUATION OF ITS USE IN THE TREATMENT OF SERIOUS INFECTIONS, PharmacoEconomics, 6(3), 1994, pp. 249-269
Citation: Mi. Wilde et al., ENALAPRIL - A REVIEW OF QUALITY-OF-LIFE AND PHARMACOECONOMIC ASPECTS OF ITS USE IN HEART-FAILURE AND MILD-TO-MODERATE HYPERTENSION, PharmacoEconomics, 6(2), 1994, pp. 155-182
Citation: Kl. Goa et Hm. Bryson, RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RGM-CSF) - AN APPRAISAL OF ITS PHARMACOECONOMIC STATUS IN NEUTROPENIA ASSOCIATED WITH CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT, PharmacoEconomics, 5(1), 1994, pp. 56-77
Citation: Hm. Bryson et Em. Sorkin, DORNASE ALFA - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN CYSTIC-FIBROSIS, Drugs, 48(6), 1994, pp. 894-906
Citation: Aj. Wagstaff et Hm. Bryson, FOSCARNET - A REAPPRAISAL OF ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN IMMUNOCOMPROMISED PATIENTS WITH VIRAL-INFECTIONS, Drugs, 48(2), 1994, pp. 199-226
Citation: Cr. Lee et Hm. Bryson, LACIDIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN THE TREATMENT OF HYPERTENSION, Drugs, 48(2), 1994, pp. 274-296
Citation: R. Davis et Hm. Bryson, LEVOFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY PHARMACOKINETICS AND THERAPEUTIC EFFICACY DRUGS (VOL 47, PG 677, 1994), Drugs, 48(1), 1994, pp. 132-132
Citation: R. Davis et Hm. Bryson, LEVOFLOXACIN A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETICSAND THERAPEUTIC EFFICACY, Drugs, 47(4), 1994, pp. 677-700
Citation: Lb. Barradell et Hm. Bryson, CEFEPIME - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE, Drugs, 47(3), 1994, pp. 471-505
Citation: Hm. Bryson et Rn. Brogden, PIPERACILLIN TAZOBACTAM - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL/, Drugs, 47(3), 1994, pp. 506-535
Citation: Hm. Bryson et Em. Sorkin, CLADRIBINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN HEMATOLOGICAL MALIGNANCIES, Drugs, 46(5), 1993, pp. 872-894
Citation: Hm. Bryson, PROPAFENONE - A REAPPRAISAL OF ITS PHARMACOLOGY, PHARMACOKINETICS ANDTHERAPEUTIC USE IN CARDIAC-ARRHYTHMIAS (VOL 45, PG 87, 1993), Drugs, 45(5), 1993, pp. 736-736
Citation: Hm. Bryson et Rn. Brogden, CEFETAMET PIVOXIL - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE, Drugs, 45(4), 1993, pp. 589-621